We are live on ! Find out more
GCM

Glenview Capital Management Portfolio holdings

AUM $3.98B
1-Year Est. Return 20.52%
This Fund
S&P 500
This Quarter Est. Return
+4.72%
1 Year Est. Return
+20.52%
3 Year Est. Return
+68.18%
5 Year Est. Return
+87.14%
10 Year Est. Return
+400.35%
AUM
$17.2B
AUM Growth
+$1.82B
Cap. Flow
+$1.19B
Cap. Flow %
6.92%
Top 10 Hldgs %
48.55%
Holding
61
New
9
Increased
21
Reduced
18
Closed
5

Top Buys

Rank Stock Value
1
SHPG
Shire pic
SHPG
+$650M
2
ZBH icon
Zimmer Biomet
ZBH
+$283M
3
MCK icon
McKesson
MCK
+$239M
4
DD icon
DuPont de Nemours
DD
+$133M
5
PNR icon
Pentair
PNR
+$113M

Sector Composition

Rank Sector Weight
1 Healthcare 43.07%
2 Materials 13.85%
3 Technology 10.28%
4 Communication Services 9.41%
5 Consumer Discretionary 8.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HCA icon
1
HCA Healthcare
HCA
$87.2B
$1.21B 7%
15,155,942
+256,653
+2% +$20.6M
DD icon
2
DuPont de Nemours
DD
$18.5B
$1.12B 6.52%
6,412,387
+798,288
+14% +$133M
FMC icon
3
FMC
FMC
$1.34B
$1.05B 6.07%
13,514,537
-1,465,590
-10% -$105M
SHPG
4
DELISTED
Shire pic
SHPG
$899M 5.22%
5,869,138
+4,146,161
+241% +$650M
IQV icon
5
IQVIA
IQV
$38.7B
$848M 4.92%
8,921,356
ELV icon
6
Elevance Health
ELV
$81.5B
$722M 4.19%
3,802,515
-248,116
-6% -$47.2M
DXC icon
7
DXC Technology
DXC
$1.82B
$672M 3.9%
9,039,855
-390,984
-4% -$27.7M
FLEX icon
8
Flex
FLEX
$41.7B
$653M 3.79%
52,327,261
+1,685,649
+3% +$20.8M
AET
9
DELISTED
Aetna Inc
AET
$603M 3.5%
3,794,484
+484,015
+15% +$75.6M
GOOGL icon
10
Alphabet (Google) Class A
GOOGL
$4.36T
$592M 3.44%
12,162,200
-176,860
-1% -$8.39M
CI icon
11
Cigna
CI
$73.7B
$576M 3.34%
3,083,753
-659,431
-18% -$117M
TMO icon
12
Thermo Fisher Scientific
TMO
$213B
$516M 3%
2,728,827
-31,138
-1% -$5.64M
ABBV icon
13
AbbVie
ABBV
$443B
$475M 2.75%
5,341,332
-768,838
-13% -$58.5M
LH icon
14
Labcorp
LH
$25B
$439M 2.55%
3,385,131
+283,085
+9% +$37.8M
MCK icon
15
McKesson
MCK
$100B
$418M 2.43%
2,720,878
+1,533,050
+129% +$239M
EBAY icon
16
eBay
EBAY
$50.6B
$402M 2.33%
10,456,699
+1,550,777
+17% +$56.4M
AAPL icon
17
Apple
AAPL
$4.54T
$384M 2.23%
9,958,128
-160,656
-2% -$6.23M
PARA
18
DELISTED
Paramount Global Class B
PARA
$381M 2.21%
6,567,902
+727,547
+12% +$46M
ZBH icon
19
Zimmer Biomet
ZBH
$18.2B
$369M 2.14%
3,250,048
+2,455,496
+309% +$283M
LOW icon
20
Lowe's Companies
LOW
$117B
$335M 1.94%
4,191,810
-2,429,799
-37% -$186M
FDC
21
DELISTED
First Data Corporation
FDC
$306M 1.78%
16,969,432
+4,750,000
+39% +$86.7M
THC icon
22
Tenet Healthcare
THC
$20.5B
$294M 1.71%
17,890,230
CAR icon
23
Avis
CAR
$4.86B
$289M 1.68%
7,598,004
-200,000
-3% -$6.73M
LBTYA icon
24
Liberty Global Class A
LBTYA
$3.62B
$263M 1.53%
7,758,465
-95,100
-1% -$3.17M
UHS icon
25
Universal Health Services
UHS
$10.2B
$255M 1.48%
2,299,484
+325,939
+17% +$36.7M

Similar funds

Glenview Capital Management's Q3 2017 Portfolio in Review

As of Q3 2017, Glenview Capital Management held 61 positions worth $17.2B, up 12% from $15.4B the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Glenview Capital Management deployed $1.19B of net new capital in Q3 2017, opening 9 new positions and adding to 21 existing holdings. Its largest new stake was Pentair: 2,637,268 shares worth $120M.

By sector, the portfolio is most concentrated in Healthcare at 43% of assets, down from 43% a quarter earlier, followed by Materials and Technology.

On the sell side, the largest reduction was Lowe's Companies, an estimated $186M trimmed.

  • Glenview Capital Management's largest Q3 2017 buy was Pentair: 2,637,268 shares worth $120M.
  • Glenview Capital Management added most to Shire pic in Q3 2017, an estimated $650M increase.
  • Glenview Capital Management's biggest Q3 2017 reduction was Lowe's Companies, cutting an estimated $186M.
  • Glenview Capital Management fully exited Humana in Q3 2017, selling an estimated $173M.
  • Glenview Capital Management's ten largest holdings make up 49% of its $17.2B portfolio in Q3 2017.
  • Glenview Capital Management opened 9 new positions and closed 5 in Q3 2017.
  • Glenview Capital Management's portfolio value rose 12% quarter-over-quarter to $17.2B.

Based on Glenview Capital Management's 13F filing for Q3 2017, filed 14 Nov 2017.